1. Targeted Tubulysin B Hydrazide Conjugate for the Treatment of Luteinizing Hormone-Releasing Hormone Receptor-Positive Cancers
   Jyoti Roy et al, 2018, Bioconjugate Chemistry CrossRef
2. Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis
   Cai-Ping Chen et al, 2022, Journal of International Medical Research CrossRef
3. Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer
   Margaret Ndinguri et al, 2023, PLOS ONE CrossRef
4. Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer
   Mark Seungwook Kim et al, 2020, Molecular Cancer Therapeutics CrossRef
5. Novel Crizotinib–GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems
   József Murányi et al, 2019, International Journal of Molecular Sciences CrossRef
6. Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers
   Jyoti Roy et al, 2019, Oncotarget CrossRef
7. A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer
   Anca Chelariu-Raicu et al, 2021, Gynecologic Oncology CrossRef
8. Synthesis of Radiolabeled Technetium- and Rhenium-Luteinizing Hormone-Releasing Hormone (99mTc/Re-Acdien-LHRH) Conjugates for Targeted Detection of Breast Cancer Cells Overexpressing the LHRH Receptor
   Lindsay E. Calderon et al, 2021, ACS Omega CrossRef
9. The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer
   Günter Emons et al, 2021, Cells CrossRef
10. Immunohistochemical Expression of LHRH Receptor in Different Compartments of Female Genital Tract in Patients With Endometrial Cancer
    Bartłomiej Barczyński et al, 2022, Applied Immunohistochemistry & Molecular Morphology CrossRef